{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T05:02:12Z","timestamp":1775192532756,"version":"3.50.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"am","delay-in-days":302,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.expneurol.2024.115030","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T06:42:37Z","timestamp":1729838557000},"page":"115030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Combination treatment with cilostazol and isosorbide mononitrate attenuates microemboli-mediated vascular cognitive impairment and improves imaging and plasma biomarkers in diabetic rats"],"prefix":"10.1016","volume":"383","author":[{"given":"Weiguo","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice A.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingju","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Voltin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianying","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eda","family":"Karakaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jazlyn","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Jamil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kareem","family":"Abdelsaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Fatima","family":"Falangola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adviye","family":"Ergul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2024.115030_bb0005","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/brain\/awab094","article-title":"Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer's disease","volume":"144","author":"Asby","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2024.115030_bb0010","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/jcbfm.2013.46","article-title":"Assessing white matter ischemic damage in dementia patients by measurement of myelin proteins","volume":"33","author":"Barker","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.expneurol.2024.115030_bb0015","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1093\/brain\/awu040","article-title":"Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia","volume":"137","author":"Barker","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2024.115030_bb0020","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","article-title":"Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications","volume":"14","author":"Biessels","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.expneurol.2024.115030_bb0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.eclinm.2019.04.001","article-title":"Tolerability, safety and intermediary pharmacological effects of cilostazol and isosorbide mononitrate, alone and combined, in patients with lacunar ischaemic stroke: the LACunar Intervention-1 (LACI-1) trial, a randomised clinical trial","volume":"11","author":"Blair","year":"2019","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.expneurol.2024.115030_bb0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/STROKEAHA.121.034866","article-title":"Effects of cilostazol and isosorbide mononitrate on cerebral hemodynamics in the LACI-1 randomized controlled trial","volume":"53","author":"Blair","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2024.115030_bb0035","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41593-020-00792-3","article-title":"Increasing the statistical power of animal experiments with historical control data","volume":"24","author":"Bonapersona","year":"2021","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2024.115030_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.147132","article-title":"Diabetic rats are more susceptible to cognitive decline in a model of microemboli-mediated vascular contributions to cognitive impairment and dementia","volume":"1749","author":"Chandran","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2024.115030_bb0045","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1042\/CS20220465","article-title":"Magnetic resonance imaging reveals microemboli-mediated pathological changes in brain microstructure in diabetic rats: relevance to vascular cognitive impairment\/dementia","volume":"136","author":"Chandran","year":"2022","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.expneurol.2024.115030_bb0050","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1445-5994.2012.02758.x","article-title":"Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies","volume":"42","author":"Cheng","year":"2012","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.expneurol.2024.115030_bb0055","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10571-016-0334-7","article-title":"The science of vascular contributions to cognitive impairment and dementia (VCID): a framework for advancing research priorities in the cerebrovascular biology of cognitive decline","volume":"36","author":"Corriveau","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2024.115030_bb0060","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jacc.2019.10.062","article-title":"Alzheimer\u2019s disease and vascular aging: JACC focus seminar","volume":"75","author":"Cortes-Canteli","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.expneurol.2024.115030_bb0065","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/cphy.c170019","article-title":"Impact of metabolic diseases on cerebral circulation: structural and functional consequences","volume":"8","author":"Coucha","year":"2018","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.expneurol.2024.115030_bb0070","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev-physiol-021119-034338","article-title":"Contributions of aging to cerebral small vessel disease","volume":"82","author":"De Silva","year":"2020","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.expneurol.2024.115030_bb0075","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.nbd.2015.08.014","article-title":"Vascular dysfunction in the pathogenesis of Alzheimer\u2019s disease--A review of endothelium-mediated mechanisms and ensuing vicious circles","volume":"82","author":"Di Marco","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2024.115030_bb0085","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/acn3.51652","article-title":"A population-based meta-analysis of circulating GFAP for cognition and dementia risk","volume":"9","author":"Gonzales","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.expneurol.2024.115030_bb0090","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.1161\/STR.0000000000000148","article-title":"Defining optimal brain health in adults: a presidential advisory from the American Heart Association\/American Stroke Association","volume":"48","author":"Gorelick","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2024.115030_bb0095","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1042\/CS20160397","article-title":"Cerebrovascular complications of diabetes: focus on cognitive dysfunction","volume":"130","author":"Hardigan","year":"2016","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.expneurol.2024.115030_bb0100","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1161\/STR.0000000000000431","article-title":"The neurovasculome: key roles in brain health and cognitive impairment: a scientific statement from the American Heart Association\/American Stroke Association","volume":"54","author":"Iadecola","year":"2023","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2024.115030_bb0105","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13024-023-00640-5","article-title":"Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer\u2019s disease","volume":"18","author":"Inoue","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2024.115030_bb0110","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1038\/ncomms11934","article-title":"Early role of vascular dysregulation on late-onset Alzheimer\u2019s disease based on multifactorial data-driven analysis","volume":"7","author":"Iturria-Medina","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2024.115030_bb0115","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s10571-016-0440-6","article-title":"The role of hypoxia-inducible factor 1 in mild cognitive impairment","volume":"37","author":"Iyalomhe","year":"2017","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2024.115030_bb0120","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s12975-019-00752-5","article-title":"Delayed administration of angiotensin II type 2 receptor (AT2R) agonist compound 21 prevents the development of post-stroke cognitive impairment in diabetes through the modulation of microglia polarization","volume":"11","author":"Jackson","year":"2020","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.expneurol.2024.115030_bb0125","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/alz.12091","article-title":"Age-stratified longitudinal study of Alzheimer\u2019s and vascular dementia patients","volume":"16","author":"Jorgensen","year":"2020","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.expneurol.2024.115030_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.711784","article-title":"Increased levels of circulating Angiogenic cells and signaling proteins in older adults with cerebral small vessel disease","volume":"13","author":"Kapoor","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.expneurol.2024.115030_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/alz.065811","article-title":"Validation and utility of plasma neurofilament light as a biomarker for vascular cognitive impairment","volume":"18","author":"Kautz","year":"2022","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.expneurol.2024.115030_bb0140","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pbb.2015.05.006","article-title":"Efficacy of Cilostazol a selective phosphodiesterase-3 inhibitor in rat model of Streptozotocin diabetes induced vascular dementia","volume":"135","author":"Kumar","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.expneurol.2024.115030_bb0145","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.nbd.2014.08.034","article-title":"Diabetes augments cognitive dysfunction in chronic cerebral hypoperfusion by increasing neuronal cell death: implication of cilostazol for diabetes mellitus-induced dementia","volume":"73","author":"Kwon","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2024.115030_bb0150","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nature09001","article-title":"Embolus extravasation is an alternative mechanism for cerebral microvascular recanalization","volume":"465","author":"Lam","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2024.115030_bb0155","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1179\/016164111X12881719352417","article-title":"Comparison of selective versus dual endothelin receptor antagonism on cerebrovascular dysfunction in diabetes","volume":"33","author":"Li","year":"2011","journal-title":"Neurol. Res."},{"key":"10.1016\/j.expneurol.2024.115030_bb0160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2023.01.002","article-title":"Whole blood transcript and protein abundance of the vascular endothelial growth factor family relate to cognitive performance","volume":"124","author":"Libby","year":"2023","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2024.115030_bb0165","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1161\/STROKEAHA.116.012066","article-title":"Vascular contributions to cognitive impairment and dementia: topical review of animal models","volume":"47","author":"Madigan","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2024.115030_bb0170","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/acn3.79","article-title":"Phosphodiesterase III inhibitor promotes drainage of cerebrovascular beta-amyloid","volume":"1","author":"Maki","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.expneurol.2024.115030_bb0175","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/S0140-6736(12)60360-2","article-title":"Diabetes and cognitive dysfunction","volume":"379","author":"McCrimmon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2024.115030_bb0180","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1161\/STROKEAHA.120.029454","article-title":"Cilostazol for secondary prevention of stroke and cognitive decline: systematic review and meta-analysis","volume":"51","author":"McHutchison","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2024.115030_bb0185","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/bpa.12331","article-title":"Pathophysiology of hypoperfusion of the precuneus in early Alzheimer\u2019s disease","volume":"26","author":"Miners","year":"2016","journal-title":"Brain Pathol."},{"key":"10.1016\/j.expneurol.2024.115030_bib316","series-title":"The Rat Brain in Stereostaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.expneurol.2024.115030_bb0195","first-page":"34","article-title":"Plasma Abeta42\/40 ratio detects early stages of Alzheimer\u2019s disease and correlates with CSF and neuroimaging biomarkers in the AB255 study","volume":"6","author":"Perez-Grijalba","year":"2019","journal-title":"J. Prev Alzheimers Dis."},{"key":"10.1016\/j.expneurol.2024.115030_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.864758","article-title":"Cerebral microvascular senescence and inflammation in diabetes","volume":"13","author":"Phoenix","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.expneurol.2024.115030_bb0205","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/jcbfm.2015.116","article-title":"Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: a review","volume":"36","author":"Poggesi","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.expneurol.2024.115030_bb0210","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1080\/13543784.2017.1364360","article-title":"Investigational phosphodiesterase inhibitors in phase I and phase II clinical trials for Alzheimer\u2019s disease","volume":"26","author":"Prickaerts","year":"2017","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.expneurol.2024.115030_bb0215","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1161\/STROKEAHA.107.496737","article-title":"Microemboli composed of cholesterol crystals disrupt the blood-brain barrier and reduce cognition","volume":"39","author":"Rapp","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2024.115030_bb0225","doi-asserted-by":"crossref","first-page":"e499","DOI":"10.1161\/STROKEAHA.120.031611","article-title":"Cognitive impairment and dementia after Stroke: design and rationale for the DISCOVERY study","volume":"52","author":"Rost","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2024.115030_bb0230","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.trci.2016.10.001","article-title":"A multicenter, randomized, placebo-controlled trial for cilostazol in patients with mild cognitive impairment: the COMCID study protocol","volume":"2","author":"Saito","year":"2016","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.expneurol.2024.115030_bb0235","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3233\/ADR-200191","article-title":"Phosphodiesterase inhibitors for Alzheimer\u2019s disease: a systematic review of clinical trials and epidemiology with a mechanistic rationale","volume":"4","author":"Sanders","year":"2020","journal-title":"J. Alzheimers Dis. Rep."},{"key":"10.1016\/j.expneurol.2024.115030_bb0240","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons","volume":"69","author":"Schneider","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2024.115030_bb0245","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.2337\/db10-1395","article-title":"Vascular dysfunction in experimental diabetes is improved by pentaerithrityl tetranitrate but not isosorbide-5-mononitrate therapy","volume":"60","author":"Schuhmacher","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.expneurol.2024.115030_bb0250","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fnins.2019.00018","article-title":"Atrial fibrillation and risk of dementia: epidemiology, mechanisms, and effect of anticoagulation","volume":"13","author":"Silva","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.expneurol.2024.115030_bb0255","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jalz.2018.07.222","article-title":"Vascular dysfunction-the disregarded partner of Alzheimer\u2019s disease","volume":"15","author":"Sweeney","year":"2019","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.expneurol.2024.115030_bb0260","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/mrm.22655","article-title":"Estimation of tensors and tensor-derived measures in diffusional kurtosis imaging","volume":"65","author":"Tabesh","year":"2011","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.expneurol.2024.115030_bb0265","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.12935","article-title":"Mediators of cerebral hypoperfusion and blood-brain barrier leakiness in Alzheimer\u2019s disease, vascular dementia and mixed dementia","volume":"31","author":"Tayler","year":"2021","journal-title":"Brain Pathol."},{"key":"10.1016\/j.expneurol.2024.115030_bb0270","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/brain\/awv025","article-title":"Post-mortem assessment of hypoperfusion of cerebral cortex in Alzheimer's disease and vascular dementia","volume":"138","author":"Thomas","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2024.115030_bb0275","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neures.2016.12.001","article-title":"Cilostazol protects against microvascular brain injury in a rat model of type 2 diabetes","volume":"117","author":"Tsukamoto","year":"2017","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.expneurol.2024.115030_bb0280","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S2213-8587(19)30405-X","article-title":"Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression","volume":"8","author":"van Sloten","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.expneurol.2024.115030_bb0285","doi-asserted-by":"crossref","first-page":"17948","DOI":"10.1523\/JNEUROSCI.1860-12.2012","article-title":"Cognitive deficits and delayed neuronal loss in a mouse model of multiple microinfarcts","volume":"32","author":"Wang","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2024.115030_bb0290","doi-asserted-by":"crossref","first-page":"H1402","DOI":"10.1152\/ajpheart.00390.2018","article-title":"Poststroke cognitive impairment and hippocampal neurovascular remodeling: the impact of diabetes and sex","volume":"315","author":"Ward","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.expneurol.2024.115030_bb0295","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.phrs.2019.01.035","article-title":"NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia","volume":"142","author":"Ward","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.expneurol.2024.115030_bb0300","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S1474-4422(19)30079-1","article-title":"Small vessel disease: mechanisms and clinical implications","volume":"18","author":"Wardlaw","year":"2019","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.expneurol.2024.115030_bb0305","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jamaneurol.2023.1526","article-title":"Isosorbide mononitrate and cilostazol treatment in patients with symptomatic cerebral small vessel disease: the lacunar intervention trial-2 (LACI-2) randomized clinical trial","volume":"80","author":"Wardlaw","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.expneurol.2024.115030_bb0310","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/alz.12215","article-title":"MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols","volume":"17","author":"Wilcock","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.expneurol.2024.115030_bb0315","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jss.2011.09.059","article-title":"Do microemboli reach the brain penetrating arteries?","volume":"176","author":"Zhu","year":"2012","journal-title":"J. Surg. Res."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448862400356X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448862400356X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T03:52:34Z","timestamp":1732938754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448862400356X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":61,"alternative-id":["S001448862400356X"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2024.115030","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination treatment with cilostazol and isosorbide mononitrate attenuates microemboli-mediated vascular cognitive impairment and improves imaging and plasma biomarkers in diabetic rats","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2024.115030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115030"}}